09:00-10:00 - Offline Registration for Conference Participation

10:00-12:00 The meeting room

Session 1 Advances in Radionuclide Diagnostics and Therapy

Moderators:Prof. Maged Abdel Galil (Egypt) Prof. Olga V. Lukina (Russia), Dr. Vyacheslav Yu. Sukhov

10:00-10:15

Mohammed Zakaria

Initial experience using PET/MRI in neurologic applications

Misr Radiology Center, Egypt

10:15-10:30

Yasmin Atteya

Applications of AI in nuclear medicine and theranostics

Misr Radiology Center, Egypt

10:30-10:45

Ruslan Varvashenya

Evaluation of HYNIC-modified novel targeted radionuclide agents for imaging HER2-expressing cancers

Siberian State Medical University, Tomsk, Russia

10:45-11:00

Tanisha Sayantani Sinha

Feasibility study of 68Ga-FAPI PET/CT in staging of non-small cell lung carcinoma and invasive ductal carcinoma of breast

Tata Memorial Center Kolkatta, India

11:00-11:15

Arina Tsigikalo

Clinical application of dynamic SPECT to determine microvascular dysfunction in patients with cardiovascular diseases

Scientific Research Center of Cardiology, Tomsk, Russia

11:15-11:30

Milolika Abakumova

Radioiodine therapy. When to say “stop”? A clinician's point of view

Kasatkin Hospital, Russian Medical Academy of Professional Education, Moscow, Russia

11:30-11:45

Marine Manucharian

PET/CT in lymphoma: reproducibility of the Deauville score.

Expert assessment Moscow, Russia

11:45-12:00

Angelina Nesterova

Investigation of the problem of accurate quantitative assessment of accumulated activity in tumor lesions using SPECT/CT method.

Novosibirsk State University, Novosibirsk, Russia

12:00-12:15

Emran Askari

Exploring Exceptional and Challenging Theranostic Cases: Insights from Iranian Nuclear Medicine Centers and the Potential for BRICS Collaboration

Mashhad University of Medical Sciences, Iran

12:15-12:45

Coffee break

12:45-14:15 The meeting room

Session 2

Clinical Cases of the Use of Advanced Methods of Radionuclide Diagnostics and Therapy

Moderators: Academician Sergey M. Deev, Dr. Vyacheslav Yu. Sukhov

Prof. Daria V. Ryzhkova

12:45-13:00

Nadezhda Legkodimova

Right decisions in the difficult cases of 177Lu-PSMA radioligand therapy in mCRPC Obninsk, Russia

13:00-13:15

Ekaterina Nikolaeva

Head-to-head comparison of 99mTc-tectrotyde and 123I-MIBG scintigraphy in neuroblastoma Moscow, Russia

13:15-13:30

Oksana Karpova

Technetium Tc-99m Pyrophosphate efficiency in Transthyretin Cardiac Amyloidosis detection: a case report

Almazov National Medical Research Center, St-Petersburg, Russia

13:30-13:45

Sofya Zarembovskaya

The use of PET/CT with 18[F]FDG for the diagnosis of heart formation: a case of a metabolically inactive blood clot in the right atrium

St-Petersburg, Russia

13:45-14:00

Vadim Ovcharov

PET/CT with [18F] FDG in the diagnosis of a complex case of sarcoidosis with cardiac and pulmonary localization: a clinical case

St-Petersburg, Russia

14:00-14:15

Anastasia Kornilova

Clinical case: Pulmonary artery intimal sarcomas

Almazov National Medical Research Center, St-Petersburg, Russia

14:15-14:45

Coffee break

14:45-15:45 The meeting room

Session 3

Clinical Cases of the Use of Advanced Methods of Radionuclide Diagnostics and Therapy (Continued)

Moderators: Prof. Sergey N. Novikov (Russia), Dr. Vyacheslav Yu. Sukhov, Prof. Daria V. Ryzhkova

14:45-15:00

Karina Pogosyan

Application of PET/CT for detection of neuroendocrine tumors in patient with MEN 1 syndrome

Almazov National Medical Research Center, St-Petersburg, Russia

15:00-15:15

Aleksandra Arzumanova

Case report: difficulties in radionuclide diagnostics in patient with pancreatic neuroendocrine tumor and metastatic renal cell carcinoma Granov Russian Scientific Center of Radiology and Surgical Technologies, St-Petersburg, Russia

15:15-15:30

Alina Valitova

Сase presentation: the use of the nanocolloid radiopharmaceutical in assessing the regional lymph node status in patients with breast cancer

St-Petersburg, Russia

15:30-15:45

Nikolay Nosov

PET/CT in the long follow-up of the patient with a pancreatic neuroendocrine tumor

Granov Russian Scientific Center of Radiology and Surgical Technologies, St-Petersburg, Russia

10:00 - 12:00 The small hall

Session 4

New Methods of the Synthesis and Quality Control in Radiopharmacy

Moderators: Prof. Anil Kumar Mishra (India), Oleg Mansurov (Russia)

10:00-10:15

Lutfi A. Hasnowo

Synthesis and Initial Preclinical Evaluation of Novel Urea-based PSMA Inhibitors

Tomsk Polytechnic University, Tomsk, Russia

10:15-10:30

Trisha Govender

Labeling process of Tc99m-HMPAO-autologous white blood cells Umhlanga Molecular Imaging Therapy Centre of Excellence, Pretoria, South Africa

10:30-10:45

Amanda Mdlophane

Labelling processes and QC with Ga-68

Nuclear Medicine Research Infrastructure, Pretoria, South Africa

10:45-11:00

Hrishi Roopa

Setting up a remote radiopharmacy - the South African perspective

Africa X-ray Industrial and Medical, Johannesburg, South Africa

11:00-11:15

Mahshid Kiani

Innovations in Radiopharmaceutical Development and Quality Control Tehran University of Medical Science, Iran

11:15-11:30

Samantha Du Plessis

Advancing Radiotherapeutics in Africa: Ensuring Sustainable and Reliable Access to I-131, Lu-177, Ac-225 and Tb-161

NTP Radioisotopes SOC., Pretoria, South Africa

11:30-11:45

Sipho Mdanda

Product and quality control of Ac-225 radiopharmaceuticals - the NuMeRi experience

Nuclear Medicine Research Infrastructure, Pretoria, South Africa

11:45-12:00

Deepsikha Sharma

Designing and developing biscyclam-triazole based radioligand: a novel theranostics agent targeting CXCR4

Banaras Hindu University, India

12:00-12:30

Coffee break

12:30 - 14:45 The small hall

Session 5

New Methods of the Synthesis and Quality Control in Radiopharmacy (Continued)

Moderators: Dr. Galina Kodina, Dr. Raisa Krasikova

12:30-12:45

Daria Vaulina

Synthesis and evaluation of anti-inflammatory activity of structural analogues of honokiol labeled with fluorine-18 in adjuvant-induced arthritis Human Brain Institute, St-Petersburg, Russia

12:45-13:00

Stepan Ermilov

Measurement of Ra-223 activity with traceability to the State Primary Standard

MEPHi, Moscow, Russia

13:00-13:15

Kirill Frolov

Development of a method for quality control of a radiopharmaceutical in a medical organization using the example of the tracer "99mTc-Tectrotyd MEPHi, Moscow, Russia

13:15-13:30

Anastasiia Kochergina

Techtenium carbonyldiketonates for introduction of Tc-99m into biomolecules

Saint Petersburg State University, St-Petersburg, Russia

13:30-13:45

Anastasiia Prach

Preclinical evaluation of a novel bivalent anti-HER2 therapeutic conjugate based on DARPin G3 fused to emtansine for the treatment of ovarian cancer Tomsk, Russia

13:45-14:00

Anna Sakhonenkova

Technetium tricarbonyl complexes with fatty acid isocyanides

Saint Petersburg State University, St-Petersburg, Russia

14:00-14:15

Gleb Yanovich

Preclinical characterization of visualization of epidermal growth factor receptor expression by targeting protein DARPin (HE)3-E01 labeled with 99mTc

Siberian State Medical University, Tomsk, Russia

14:15-14:30

Vitalina Bodenko

Half-life extension via ABD fusion of an affibody drug conjugate compared to PAS and XTENylation

Tomsk Polytechnic University, Tomsk, Russia

14:30-14:45

Anastasia Fominykh

EpCAM imaging capabilities in malignant neoplasms using new DARPin-Ec1 variants labeled with 99mTc, in vitro and in vivo

Tomsk Polytechnic University, Tomsk, Russia